[1]
|
Lloyd-Jones, D.M., Wang, T.J., Leip, E.P., Larson, M.G., Levy, D., Vasan, R.S., et al. (2004) Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation, 110, 1042-1046.
doi:10.1161/01.CIR.0000140263.20897.42
|
[2]
|
Stewart, S., Murphy, N.F., Walker, A., McGuire, A. and McMurray, J.J. (2004) Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK. Heart, 90, 286-292. doi:10.1136/hrt.2002.008748
|
[3]
|
Benjamin, E., Wolf, P., D’Agostino, R., Silbershatz, H., Kannel, W. and Levy, D. (1998) Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation, 98, 946-952.
doi:10.1161/01.CIR.98.10.946
|
[4]
|
Stewart, S., Hart, C.L., Hole, D.J. and McMurray, J.J. (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. American Journal of Medicine, 113, 359-364. doi:10.1016/S0002-9343(02)01236-6
|
[5]
|
Sugishita, K., Shiono, E., Sugiyama, T. and Ashida, T. (2003) Diabetes influences the cardiac symptoms related to atrial fibrillation. Circulation Journal, 67, 835-888.
doi:10.1253/circj.67.835
|
[6]
|
Gage, B.F., van Walraven, C., Pearce, L., Hart, R.G., Koudstaal, P.J., Boode, B.S.P., et al. (2004) Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin. Circulation, 110, 2287-2292.
|
[7]
|
Gage, B.F., Waterman, A.D., Shannon, W., Boechler, M., Rich, M.W. and Radford, M.J. (2001) Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation. Journal of the American Medicine Association, 285, 2864-2870.
|
[8]
|
Wilhelmsen, L., Rosengren, A. and Lappas, G. (2001) Hospitalizations for atrial fibrillation in the general male population: Morbidity and risk factors. Journal of Internal Medicine, 250, 382-389.
doi:10.1046/j.1365-2796.2001.00902.x
|
[9]
|
Movahed, M., Hashemzadeh, M. and Jamal, M. (2005) Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. International Journal of Cardiology, 105, 315-321. doi:10.1016/j.ijcard.2005.02.050
|
[10]
|
Nichols, G.A., Reinier, K. and Chugh, S.S. (2009) Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care, 32, 1851-1856. doi:10.2337/dc09-0939
|
[11]
|
Aksnes, T., Schmieder, R., Kjeldsen, S., Ghani, S., Hua, T. and Julius, S. (2008) Impact of New-Onset Diabetes Mellitus on Development of Atrial Fibrillation and Heart Failure in High-Risk Hypertension (from the VALUE Trial). American Journal of Cardiology, 101, 634-638.
doi:10.1016/j.amjcard.2007.10.025
|
[12]
|
Benjamin, E.J, Wolf, P.A., D’Agostino, R.B., Silbershatz, H., Kannel, W.B. and Levy, D. (1998) Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study. Circulation, 98, 946-952.
|
[13]
|
Ostgren, C.J., Merlo, J., Rastam, L. and Lindblad, U. (2004) Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes, Obesity and Metabolism, 6, 367-374.
doi:10.1111/j.1462-8902.2004.00358.x
|
[14]
|
Psaty, B.M., Manolio, T.A., Kuller, L.H., Kronmal, R.A, Cushman, M., Fried, L.P., et al. (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 96, 2455-2461. doi:10.1161/01.CIR.96.7.2455
|
[15]
|
Johansen, O., Brustad, E., Enger, S. and Tveit, A. (2008) Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects. Cardiovascular Diabetology, 7, 28.
doi:10.1186/1475-2840-7-28
|
[16]
|
Stritzke, J., Markus, M.R.P., Duderstadt, S., Lieb, W., Luchner, A., Doring, A., et al. (2009) The Aging Process of the Heart: Obesity Is the Main Risk Factor for Left Atrial Enlargement During Aging: The MONICA/KORA (Monitoring of Trends and Determinations in Cardiovascular Disease/Cooperative Research in the Region of Augsburg) Study. Journal of the American College of Cardiology, 54, 1982-1989.
doi:10.1016/j.jacc.2009.07.034
|
[17]
|
Wasada, T., Katsumori, K., Hasumi, S., Kasanuki, H., Arii, H., Saeki, A., et al. (1995) Association of sick sinus syndrome with hyperinsulinemia and insulin resistance in patients with non-insulin-dependent diabetes mellitus: Report of four cases. Internal Medicine, 34, 1174-1177.
doi:10.2169/internalmedicine.34.1174
|
[18]
|
Gandhi, G., Nuttall, G., Abel, M., Mullany, C., Schaff, H., Williams, B., et al. (2005) Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clinic Proceedings, 80, 862-866.
doi:10.4065/80.7.862
|
[19]
|
Lazar, H.L., Chipkin, S.R., Fitzgerald, C.A., Bao, Y., Cabral, H. and Apstein, C.S. (2004) Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation, 109, 1497-502.
doi:10.1161/01.CIR.0000121747.71054.79
|
[20]
|
Rutter, M.K., Parise, H., Benjamin, E.J., Levy, D., Larson, M.G., Meigs, J.B., et al. (2003) Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study. Circulation, 107, 448-454.
|
[21]
|
Lind, L., Berne, C., Andren, B. and Lithell, H. (1996) Relationship between diastolic hypertension and myocardial morphology and function in elderly males with diabetes mellitus. Diabetologia, 39, 1603-1606.
doi:10.1007/s001250050621
|
[22]
|
Sundstrom, J., Lind, L., Nystrom, N., Zethelius, B., Andren, B., Hales, C.N., et al. (2000) Left Ventricular Concentric Remodeling Rather Than Left Ventricular Hypertrophy Is Related to the Insulin Resistance Syndrome in Elderly Men. Circulation, 101, 2595-2600.
|
[23]
|
Palmieri, V., Bella, J.N., Arnett, D.K., Liu, J.E., Oberman, A., Schuck, M.-Y., et al. (2001) Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation, 103, 102-107.
|
[24]
|
Galvan, A.Q., Galetta, F., Natali, A., Muscelli, E., Sironi, A.M., Cini, G., et al. (2000) Insulin Resistance and Hyperinsulinemia: No Independent Relation to Left Ventricular Mass in Humans. Circulation, 102, 2233-2238.
|
[25]
|
Uusitupa, M., Siitonen, O., Pyorala, K., Mustonen, J., Voutilainen, E., Hersio, K., et al. (1987) Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed non-insulin-dependent (type 2) diabetic patients and in non-diabetic subjects. Diabetes Research, 4, 19-25.
|
[26]
|
Verdecchia, P., Reboldi, G., Schillaci, G., Borgioni, C., Ciucci, A., Telera, M.P., et al. (1999) Circulating Insulin and Insulin Growth Factor-1 Are Independent Determinants of Left Ventricular Mass and Geometry in Essential Hypertension. Circulation, 100, 1802-1807.
|
[27]
|
Young, M.E., McNulty, P. and Taegtmeyer, H. (2002) Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms. Circulation, 105, 1861-1870.
|
[28]
|
Collier, A., Matthews, D.M., Young, R.J. and Clarke, B.F. (1987) Transient atrial fibrillation precipitated by hypoglycaemia: Two case reports. Postgraduate Medical Journal, 63, 895-897. doi:10.1136/pgmj.63.744.895
|
[29]
|
Odeh, M., Oliven, A. and Bassan, H. (1990) Transient atrial fibrillation precipitated by hypoglycemia. Annals of Emergency Medicine, 19, 565-567.
doi:10.1016/S0196-0644(05)82191-2
|
[30]
|
Baxter, M.A., Garewal, C., Jordan, R., Wright, A.D. and Nattrass, M. (1990) Hypoglycaemia and atrial fibrillation. Postgraduate Medical Journal, 66, 981.
doi:10.1136/pgmj.66.781.981
|
[31]
|
Lip, G.Y. and Varughese, G.I. (2005) Diabetes mellitus and atrial fibrillation: Perspectives on epidemiological and pathophysiological links. International Journal of Cardiology 105, 319-321.
doi:10.1016/j.ijcard.2005.03.003
|
[32]
|
Pollock, G., Brady, W.J., Jr., Hargarten, S., DeSilvey, D. and Carner, C.T. (1996) Hypoglycemia manifested by sinus bradycardia: A report of three cases. Academic Emergency Medicine, 3, 700-707.
doi:10.1111/j.1553-2712.1996.tb03495.x
|
[33]
|
Gill, G.V., Woodward, A., Casson, I.F. and Weston, P.J. (2009) Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the “dead in bed” syndrome revisited. Diabetologia, 52, 42-45. doi:10.1007/s00125-008-1177-7
|
[34]
|
Marques, J.L., George, E., Peacey, S.R., Harris, N.D., Macdonald, I.A., Cochrane, T., et al. (1997) Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabetic Medicine, 14, 648-654.
doi:10.1002/(SICI)1096-9136(199708)14:8<648::AID-DIA418>3.0.CO;2-1
|
[35]
|
Robinson, R.T., Harris, N.D., Ireland, R.H., Macdonald, I.A. and Heller, S.R. (2004) Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes. Diabetologia, 47, 312-315. doi:10.1007/s00125-003-1292-4
|
[36]
|
(1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Archives of Internal Medicine, 154, 1449-1157.
doi:10.1001/archinte.1994.00420130036007
|
[37]
|
Laakso, M. (1999) Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes, 48, 937-942.
|
[38]
|
Jaffar, A.R. and Assad, M. (2003) Current concepts of cardiovascular diseases in diabetes mellitus. International Journal of Cardiology, 89, 123-134.
doi:10.1016/S0167-5273(02)00510-7
|
[39]
|
Nesto, R.W. (2004) Correlation between cardiovascular disease and diabetes mellitus: Current concepts. American Journal of Medicine, 116, 11S-22S.
|
[40]
|
Kannel, W.B. (1985) Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study. American Heart Journal, 110, 1100-1107.
doi:10.1016/0002-8703(85)90224-8
|
[41]
|
Milicevic, Z., Raz, I., Beattie, S.D., Campaigne, B.N., Sarwat, S., Gromniak, E., et al. (2008) Natural history of cardiovascular disease in patients with diabetes: Role of hyperglycemia. Diabetes Care, 31, S155-S160.
|
[42]
|
Goraya, T.Y., Leibson, C.L., Palumbo, P.J., Weston, S.A., Killian, J.M., Pfeifer, E.A., et al. (2002) Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. Journal of the American College of Cardiology, 40, 946-953. doi:10.1016/S0735-1097(02)02065-X
|
[43]
|
Hansson, L., Zanchetti, A., Carruthers S.G., Dahlof, B., Elmfeldt, D., Julius, S., et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet, 351, 1755-1762.
doi:10.1016/S0140-6736(98)04311-6
|
[44]
|
Cushman, W.C., Evans, G.W., Byington, R.P., Goff, D.C., Jr., Grimm, R.H., Jr., Cutler, J.A., et al. (1575) Effects of intensive blood-pressure control in type 2 diabetes mellitus. The New England Journal of Medicine, 362, 1575-1585.
|
[45]
|
L’Allier, P.L., Ducharme, A., Keller, P.F., Yu, H., Guertin, M.C. and Tardif, J.C. (2004) Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. Journal of the American College of Cardiology, 44, 159-164. doi:10.1016/j.jacc.2004.03.056
|
[46]
|
Disertori, M., Latini, R., Barlera, S., Franzosi, M.G., Staszewsky, L., Maggioni, A.P., et al. (2009) Valsartan for prevention of recurrent atrial fibrillation. The New England Journal of Medicine, 360, 1606-1617.
doi:10.1056/NEJMoa0805710
|
[47]
|
Kalus, J.S., Coleman, C.I. and White, C.M. (2006) The impact of suppressing the renin-angiotensin system on atrial fibrillation. The Journal of Clinical Pharmacology, 46, 21-28. doi:10.1177/0091270005283284
|
[48]
|
Anand, K., Mooss, A.N., Hee, T.T. and Mohiuddin, S.M. (2006) Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. American Heart Journal, 152, 217-222. doi:10.1016/j.ahj.2006.01.007
|
[49]
|
Jibrini, M.B., Molnar, J. and Arora, R.R. (2008) Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: A systematic review and meta- analysis. The American Journal of Therapeutics, 15, 36- 43. doi:10.1097/MJT.0b013e31804beb59
|
[50]
|
Korantzopoulos, P., Kokkoris, S., Kountouris, E., Pro- topsaltis, I., Siogas, K. and Melidonis, A. (2008) Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy. International Journal of Cardiology, 125, e51-e53. doi:10.1016/j.ijcard.2006.12.063
|
[51]
|
Qayyum, R. and Adomaityte, J. (2006) Meta-analysis of the effect of thiazolidinediones on serum C-reactive protein levels. American Journal of Cardiology, 97, 655-658.
doi:10.1016/j.amjcard.2005.09.105
|
[52]
|
Da Ros, R., Assaloni, R. and Ceriello, A. (2004) The preventive anti-oxidant action of thiazolidinediones: A new therapeutic prospect in diabetes and insulin resistance. Diabetic Medicine, 21, 1249-1252.
doi:10.1111/j.1464-5491.2004.01312.x
|